Ranolazine depresses conduction of rapid atrial depolarizations in a beating rabbit heart model
Autore
Aidonidis I., Simopoulos V., Stravela S., Dipla K., Stamatiou R., Hatziefthimiou A., Molyvdas P.-A.Data
2021Language
en
Soggetto
Abstract
Purpose: Previous clinical studies have shown that ranolazine (RAN) added to amiodarone (AMIO) might accelerate the termination of recent-onset atrial fibrillation. This study was undertaken to delineate possible mechanisms that contribute to the enhancement of the antiarrhythmic efficacy of RAN-AMIO coadministration. Methods: Ten rabbits were anesthetized and two monophasic action potential (MAP) catheters were sequentially inserted into the right atrium. One MAP electrode was used to pace and record; the other electrode was used only for recording MAP from an adjacent atrial region. Intraatrial conduction time (IACT), 2:1 intraatrial conduction block (IACB), and atrial post-repolarization refractoriness (aPRR) were consecutively determined by high-rate atrial burst pacing and programmed stimulation, respectively. All parameters were evaluated during baseline and following AMIO (3 mg/kg iv) or AMIO+RAN (2.4 mg/kg iv bolus +0.134 mg/kg/min maintenance infusion). Results: The IACT remained unchanged post AMIO compared with baseline (37.6 ± 3.8 vs 36.4 ± 2.4 ms), whereas the addition of RAN to AMIO significantly prolonged IACT (50.4 ± 3.6 ms, p <.001). The pacing cycle length producing 2:1 IACB was 101.2 ± 21.7 ms at baseline , 117.5 ± 15 ms after AMIO (p = 0.265), and 150 ± 14 ms after AMIO+RAN (p <.001). Baseline aPRR was longer following AMIO treatment (35 ± 5 vs 50 ± 9 ms, p <.01) but remarkably prolonged with RAN supplementation (105 ± 11 ms, p <.001). Conclusions: RAN significantly prolonged the propagation time of rapid atrial depolarizations and potentiated the AMIO-induced moderate increases in aPRR. These mechanisms possibly contribute to the earlier termination of atrial fibrillation when RAN is co-administered with AMIO. © 2020, Springer Science+Business Media, LLC, part of Springer Nature.
Collections
Related items
Showing items related by title, author, creator and subject.
-
Risk in atrial fibrillation: left atrial function matters
Triposkiadis F., Xanthopoulos A., Parissis J. (2019)[No abstract available] -
Measurement of Midregional Pro-Atrial Natriuretic Peptide to Discover Atrial Fibrillation in Patients With Ischemic Stroke
Schweizer J., Arnold M., König I.R., Bicvic A., Westphal L.P., Schütz V., Inauen C., Scherrer N., Luft A., Galovic M., Ferreira Atuesta C., Pokorny T., Arnold M., Fischer U., Bonati L.H., De Marchis G.M., Kahles T., Nedeltchev K., Cereda C.W., Kägi G., Bustamante A., Montaner J., Ntaios G., Sagris D., Foerch C., Spanaus K., von Eckardstein A., Katan M. (2022)Background: Midregional pro-atrial natriuretic peptide (MR-proANP) is a promising biomarker to differentiate the underlying etiology of acute ischemic stroke (AIS). Objectives: This study aimed to determine the role of ... -
Stroke risk stratification in patients with heart failure and sinus rhythm
Sagris D., Shantsila E., Lip G.Y.H. (2022)[No abstract available]